Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.3B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Advanced Micro Devices
AMD
|
+$925M |
| 4 |
S&P Global
SPGI
|
+$894M |
| 5 |
Tesla
TSLA
|
+$716M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$1.08B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$972M |
| 3 |
Merck
MRK
|
+$295M |
| 4 |
Exelon
EXC
|
+$259M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.39% |
| 2 | Financials | 13.32% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Hydrofarm Holdings
HYFM
$9.15M
| $10.4M | ﹤0.01% |
68,457
+4,616
| +7% | +$861K |
|
2327
OneSpaWorld
OSW
$2.7B
| $10.4M | ﹤0.01% |
1,015,100
+60,564
| +6% | +$617K |
|
2328
Titan Machinery
TITN
$454M
| $10.3M | ﹤0.01% |
364,883
-28,302
| -7% | -$858K |
|
2329
Argan
AGX
$8.66B
| $10.3M | ﹤0.01% |
252,947
+5,483
| +2% | +$215K |
|
2330
Par Pacific Holdings
PARR
$4.16B
| $10.3M | ﹤0.01% |
787,366
+27,425
| +4% | +$391K |
|
2331
Ducommun
DCO
$2.89B
| $10.2M | ﹤0.01% |
195,421
+4,712
| +2% | +$224K |
|
|
VRAY
2332
DELISTED
ViewRay, Inc.
VRAY
| $10.2M | ﹤0.01% |
2,604,820
+202,149
| +8% | +$860K |
|
2333
QuinStreet
QNST
$898M
| $10.2M | ﹤0.01% |
877,602
+5,022
| +0.6% | +$67.5K |
|
2334
Kanzhun
BZ
$7.35B
| $10.2M | ﹤0.01% |
410,201
+118,493
| +41% | +$3.45M |
|
|
EGRX
2335
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $10.2M | ﹤0.01% |
205,122
+720
| +0.4% | +$34.6K |
|
2336
Organogenesis Holdings
ORGO
$305M
| $10.1M | ﹤0.01% |
1,331,452
+379,505
| +40% | +$2.94M |
|
|
STEL
2337
DELISTED
Stellar Bancorp
STEL
| $10.1M | ﹤0.01% |
326,996
+11,466
| +4% | +$349K |
|
|
CATC
2338
DELISTED
CAMBRIDGE BANCORP
CATC
| $10.1M | ﹤0.01% |
119,081
+4,381
| +4% | +$385K |
|
|
JOYY
2339
JOYY Inc
JOYY
$3.77B
| $10.1M | ﹤0.01% |
276,570
+25,037
| +10% | +$1.13M |
|
2340
TaskUs
TASK
$599M
| $10.1M | ﹤0.01% |
261,993
+21,278
| +9% | +$749K |
|
|
ALBO
2341
DELISTED
Albireo Pharma Inc
ALBO
| $10.1M | ﹤0.01% |
337,493
+39,201
| +13% | +$1.15M |
|
|
INBX
2342
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $10M | ﹤0.01% |
450,440
+20,558
| +5% | +$525K |
|
2343
Arcturus Therapeutics
ARCT
$177M
| $10M | ﹤0.01% |
370,983
-4,130
| -1% | -$105K |
|
2344
Koppers
KOP
$1,000M
| $9.94M | ﹤0.01% |
361,175
+9,803
| +3% | +$289K |
|
2345
Douglas Elliman
DOUG
$160M
| $9.94M | ﹤0.01% |
1,429,055
+32,908
| +2% | +$250K |
|
2346
Cytek Biosciences
CTKB
$553M
| $9.93M | ﹤0.01% |
921,140
+566,000
| +159% | +$7.64M |
|
2347
Veritone
VERI
$112M
| $9.92M | ﹤0.01% |
542,909
+38,244
| +8% | +$658K |
|
|
HIBB
2348
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $9.92M | ﹤0.01% |
223,837
-77,528
| -26% | -$4.2M |
|
|
NAPA
2349
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $9.91M | ﹤0.01% |
545,029
-19,687
| -3% | -$384K |
|
2350
Qfin Holdings
QFIN
$1.65B
| $9.91M | ﹤0.01% |
646,178
+55,211
| +9% | +$1.03M |
|
Similar funds
Geode Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Geode Capital Management held 5,100 positions worth $801B, down 3.5% from $830B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Geode Capital Management's Q1 2022 filing shows 137 new, 3,082 increased, 1,102 reduced and 125 closed positions. Its largest new stake was Constellation Energy: 5,541,478 shares worth $311M. The largest sale was Xilinx Inc, an estimated $1.08B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q1 2022 buy was Constellation Energy: 5,541,478 shares worth $311M.
- Geode Capital Management added most to Apple in Q1 2022, an estimated $1.3B increase.
- Geode Capital Management's biggest Q1 2022 reduction was Merck, cutting an estimated $295M.
- Geode Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $1.08B.
- Geode Capital Management's ten largest holdings make up 24% of its $801B portfolio in Q1 2022.
- Geode Capital Management opened 137 new positions and closed 125 in Q1 2022.
- Geode Capital Management's portfolio value fell 3.5% quarter-over-quarter to $801B.
Based on Geode Capital Management's 13F filing for Q1 2022, filed 13 May 2022.